CN101991638A - Medicine composition for treating facial paralysis as well as preparation method and application thereof - Google Patents
Medicine composition for treating facial paralysis as well as preparation method and application thereof Download PDFInfo
- Publication number
- CN101991638A CN101991638A CN201010560640XA CN201010560640A CN101991638A CN 101991638 A CN101991638 A CN 101991638A CN 201010560640X A CN201010560640X A CN 201010560640XA CN 201010560640 A CN201010560640 A CN 201010560640A CN 101991638 A CN101991638 A CN 101991638A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- facial paralysis
- pharmaceutical composition
- hedysari
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine composition for treating facial paralysis as well as a preparation method and application thereof, belonging to the field of medicines. The medicine composition is prepared from the following raw materials in weight ratio: 5-7 parts of Chinese angelica, 5-7 parts of milkvetch roots or 3-7 parts of rhodiolae roots, 1-2 parts of scorpion, 2-4 parts of earthworm, 1-3 parts of centipede, 2-4 parts of stiff silkworm and 2-4 parts of cicada slough. The medicine composition for treating facial paralysis has obvious effect and can improve the syndromes of unfree cheek movement, side inclination, mouth corner ptosis and incapability of raising eyebrows, frowning, closing the eyes, blasting air, pouting and the like caused by completed paralyzed facial pathetic muscle.
Description
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of pharmaceutical composition for the treatment of facial paralysis and its production and use.
Background technology
Facial paralysis, the non-specific facial paralysis of formal name used at school (or claiming peripheral facial paralysis), be commonly called as "
Face ", " facial paralysis " etc., be to be a kind of commonly encountered diseases of principal character with facial expression muscle group dyskinesia, general symptom is a mouthful eye
Tiltedly.Patient's face is often the most basic lifts eyebrow, close one's eyes, the drum cheek, action such as pout one's lips as a signal all can't be finished.
The existing facial paralysis that studies show that is because of due to the peripheral nerve injury, common treatment means has acupuncture, paste medicine, cup, cut control, fiery pin, acusector, physical therapy, nasal obstruction medicine, interventional therapy, facial injectable drug etc. and some local methods among the people (as wiping Sanguis Monopteri albi) etc.Can be used for treating facial paralysis as QIANZHENGSAN, facial paralysis health in the street drug.
Based on above-mentioned present situation, the invention human desires provides a kind of brand-new medicine to be used for the treatment of or improves to paralyse fully because of facial expression muscle and causes ineffective, the Ipsilateral of buccal action
Tiltedly, ptosis of labial angle, sick side can not be made the wrinkle volume, be frowned, close order, air-blowing and the symptom of action such as be in a pout.
Summary of the invention
Technical problem solved by the invention provides a kind of brand-new medicinal composition and is used for the treatment of facial paralysis.
Pharmaceutical composition of the present invention is the medicament that is prepared from by following materials of weight proportions medicine:
Radix Angelicae Sinensis 5-7 part, Radix Astragali 5-7 part or Radix Hedysari 3-5 part, Scorpio 1-3 part, Pheretima 2-4 part, Scolopendra 1-3 part, Bombyx Batryticatus 2-4 part, Periostracum Cicadae 2-4 part.The Radix Astragali and Radix Hedysari can exchange in the pharmaceutical composition of the present invention, and consumption is slightly different, and pharmaceutical composition of the present invention can adopt following two schemes:
Radix Angelicae Sinensis 5-7 part, Radix Astragali 5-7 part, Scorpio 1-3 part, Pheretima 2-4 part, Scolopendra 1-3 part, Bombyx Batryticatus 2-4 part, Periostracum Cicadae 2-4 part; Or
Radix Angelicae Sinensis 5-7 part, Radix Hedysari 3-5 part, Scorpio 1-3 part, Pheretima 2-4 part, Scolopendra 1-3 part, Bombyx Batryticatus 2-4 part, Periostracum Cicadae 2-4 part.
Further preferred: 7 parts of Radix Angelicae Sinensis, 5 parts of the Radixs Astragali or 3 parts of Radix Hedysari, 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of Periostracum Cicadaes.Be that pharmaceutical composition of the present invention can adopt following two technical schemes:
7 parts of Radix Angelicae Sinensis, 5 parts of the Radixs Astragali, 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of Periostracum Cicadaes; Or
7 parts of Radix Angelicae Sinensis, 3 parts of Radix Hedysari, 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of Periostracum Cicadaes.
Take pharmaceutical composition of the present invention and can obviously improve ineffective, the Ipsilateral of buccal action due to the facial paralysis
Tiltedly, ptosis of labial angle, can not make the wrinkle volume, frown, close order, air-blowing and the symptom of action such as be in a pout.
Sum up through prolonged application, the present invention also provides a kind of pharmaceutical composition for the treatment of the facial paralysis more remarkable treatment effect, be to have added Radix Platycodonis, Rhizoma Chuanxiong, Radix Rhodiolae, Radix Ginseng (or Radix Ginseng Rubra) on the basis of aforementioned pharmaceutical composition, preferred pharmaceutical composition is the medicament that is prepared from by following materials of weight proportions medicine:
Radix Angelicae Sinensis 5-7 part, Radix Astragali 5-7 part (or Radix Hedysari 3-5 part), Scorpio 1-3 part, Pheretima 2-4 part, Scolopendra 1-3 part, Bombyx Batryticatus 2-4 part, Periostracum Cicadae 2-4 part, Radix Rehmanniae 3-5 part (or Radix Rehmanniae Preparata 1-3 part), Radix Platycodonis 1-2 part, Rhizoma Chuanxiong 2-4 part, Radix Rhodiolae 5-7 part, Radix Ginseng 1-3 part (or Radix Ginseng Rubra 5-7 part).The Radix Astragali is close with the Radix Hedysari effect in this pharmaceutical composition, and the Radix Rehmanniae is close with the Radix Rehmanniae Preparata effect, and the people participates in that the Radix Ginseng Rubra effect is close, and the two is interchangeable, but finds in using that Radix Hedysari invigorating the spleen and replenishing QI effect is better than the Radix Astragali; The Radix Rehmanniae Preparata blood tonification effect is better than the Radix Rehmanniae, but grows greasy imapirment of the spleen and stomach, and Radix Rehmanniae removing heat from blood is enriched blood, and is difficult for damaging the spleen and stomach, multiselect Radix Rehmanniae during clinical practice; Radix Ginseng Rubra is the cultivation product of Radix Ginseng, and QI invigorating is gentle than Radix Ginseng, so the normal Radix Ginseng Rubra that adopts.
One step is preferred, 2 parts of 3 parts in 5 parts of 7 parts of Radix Angelicae Sinensis, the Radix Astragali (or Radix Hedysari 3 parts), 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of Periostracum Cicadaes, the Radix Rehmanniae (or Radix Rehmanniae Preparata 1 part), 1 part of Radix Platycodonis, 2 parts of Rhizoma Chuanxiongs, 5 parts of Radix Rhodiolaes, Radix Ginsengs (or Radix Ginseng Rubra 5 parts).
Pharmaceutical composition of the present invention is to adopt the above-mentioned raw materials medicine, adds the medicament that acceptable accessories is prepared from according to conventional method; Mainly based on oral formulations.At the application characteristic of medicine of the present invention, also provide this preparation of drug combination method.
Method one: each crude drug is ground into fine powder, mix powder.
Method two: each crude drug is ground into fine powder, makes pill according to a conventional method.
Method three: each crude drug is ground into fine powder, is pressed into tablet according to a conventional method.
Method four: each crude drug is ground into fine powder, makes capsule according to a conventional method.Encapsulated as fine powder being mixed the back, or fine powder granulation back is encapsulated.
Method five: with each raw material routinely the decocting mode boil.
Use said method and all can realize improving the purpose of facial paralysis symptom, but easy in response to the convenience of usefulness and preparation, the inventor is made into capsule more and uses.
Pharmaceutical composition of the present invention also can be used for treating facial paralysis (being called central facial palsy again) after the cerebrovascular accident, and its symptom mainly shows as the Ipsilateral face
Tiltedly, ptosis of labial angle, action such as can not do air-blowing and be in a pout, but the volume that can wrinkle, frown, close order.
To sum up, use pharmaceutical composition provided by the invention and all can improve or treat peripheral facial paralysis facial paralysis and central facial palsy, especially cause ineffective, the face of buccal action at paralysing fully because of facial expression muscle
Tiltedly, ptosis of labial angle, sick side can not make the wrinkle volume, frown, close order, air-blowing and the symptom of action such as be in a pout has clear and definite therapeutic effect, stable curative effect, controlled.
The specific embodiment
Below by specific description of embodiments of the present invention the explanation but do not limit the present invention.
Pharmaceutical composition of the present invention is to be prepared from by following materials of weight proportions medicine: Radix Angelicae Sinensis 5-7 part, Radix Astragali 5-7 part (or Radix Hedysari 3-5 part), Scorpio 1-3 part, Pheretima 2-4 part, Scolopendra 1-3 part, Bombyx Batryticatus 2-4 part, Periostracum Cicadae 2-4 part.Crude drug floats in this amount ranges all can realize improving the purpose of facial paralysis symptom.
Find that through inventor's long-term practice 5 parts of 7 parts of Radix Angelicae Sinensis, the Radix Astragali (or Radix Hedysari 3 parts), 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of effects of Periostracum Cicadae are clearer and more definite, more stable.
Further preferred, in order to strengthen, stablize curative effect, crude drug also contains Radix Platycodonis, Rhizoma Chuanxiong, Radix Rhodiolae, Radix Ginseng, and the crude drug weight proportion is as follows:
Radix Angelicae Sinensis 5-7 part, Radix Astragali 5-7 part (or Radix Hedysari 3-5 part), Scorpio 1-3 part, Pheretima 2-4 part, Scolopendra 1-3 part, Bombyx Batryticatus 2-4 part, Periostracum Cicadae 2-4 part, Radix Rehmanniae 3-5 part (or Radix Rehmanniae Preparata 1-3 part), Radix Platycodonis 1-2 part, Rhizoma Chuanxiong 2-4 part, Radix Rhodiolae 5-7 part, Radix Ginseng 1-3 part (or Radix Ginseng Rubra 5-7 part).
Further preferred, pharmaceutical composition of the present invention adopts following materials of weight proportions medicine, and its curative effect is clearer and more definite, more stable: 2 parts of 3 parts in 5 parts of 7 parts of Radix Angelicae Sinensis, the Radix Astragali (or Radix Hedysari 3 parts), 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of Periostracum Cicadaes, the Radix Rehmanniae (or Radix Rehmanniae Preparata 1 part), 1 part of Radix Platycodonis, 2 parts of Rhizoma Chuanxiongs, 5 parts of Radix Rhodiolaes, Radix Ginsengs (or Radix Ginseng Rubra 5 parts).
The Radix Astragali described in the above-mentioned raw materials medicine adopts Radix Astragali Preparata; Described Radix Hedysari adopts Radix Hedysari Preparata; Radix Ginseng can also adopt Radix Ginseng Rubra to replace: Radix Ginseng Rubra is the cultivation product of Radix Ginseng, and QI invigorating is gentle than Radix Ginseng, so the normal Radix Ginseng Rubra that adopts.
For the ease of using, can on the basis of crude drug, add acceptable accessories and make oral formulations commonly used.As powder, pill, tablet, capsule, water decoction.
Pharmaceutical composition of the present invention causes ineffective, the Ipsilateral of buccal action at paralysing fully because of facial expression muscle
Tiltedly, ptosis of labial angle, can not make the wrinkle volume, frown, close order, air-blowing and the doing well,improving effect of action such as be in a pout remarkable, stable curative effect, controlled.Therapeutic effect at apoplectic hemiplegia is also more obvious.
Below beneficial effect by clinical statistics proof pharmaceutical composition of the present invention.
It is clinical that the inventor adopts pharmaceutical composition of the present invention to be applied to, and specifically is to be made into capsule to use, and preparation method is as follows:
1, capsule A: get following materials of weight proportions medicine: 7 parts of Radix Angelicae Sinensis, 3 parts of Radix Hedysari, 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of Periostracum Cicadaes, pulverize the back and mix encapsulated.Every capsules contains crude drug 0.4g.
2, capsule B: get following materials of weight proportions medicine: 7 parts of Radix Angelicae Sinensis, 3 parts of Radix Hedysari, 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of Periostracum Cicadaes, 3 parts in the Radix Rehmanniae, 1 part of Radix Platycodonis, 2 parts of Rhizoma Chuanxiongs, 5 parts of Radix Rhodiolaes, 5 parts of Radix Ginseng Rubra, pulverize the back and mix encapsulated.Every capsules contains crude drug 0.4g.
Control drug: commercially available QIANZHENGSAN and DAHUOLUO WAN.
Oral powder pharmaceutical composition of the present invention and control drug, medicine adult taking dose of the present invention is each 1.2g, and three times on the one, be 15 days the course of treatment, and the therapeutic effect statistical data sees Table 1-2:
Table 1
Table 2
Pharmaceutical composition of the present invention is year clinical observation surplus ten, determines with Radix Angelicae Sinensis, the Radix Astragali or Radix Hedysari, Scorpio, Pheretima, Scolopendra, Bombyx Batryticatus, Periostracum Cicadae, the Radix Rehmanniae, Radix Platycodonis, Rhizoma Chuanxiong, Radix Rhodiolae, Radix Ginseng at last behind the screening prescription.Be crude drug, therapeutic effect the best, and determine that its proportion relation is: 2 parts of 3 parts in 5 parts of 7 parts of Radix Angelicae Sinensis, the Radix Astragali (or Radix Hedysari 3 parts), 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of Periostracum Cicadaes, the Radix Rehmanniae (or Radix Rehmanniae Preparata 1 part), 1 part of Radix Platycodonis, 2 parts of Rhizoma Chuanxiongs, 5 parts of Radix Rhodiolaes, Radix Ginsengs (or Radix Ginseng Rubra 5 parts) therapeutic effect is clear and definite, stable curative effect.Radix Hedysari invigorating the spleen and replenishing QI effect is better than the Radix Astragali in the application; The Radix Rehmanniae Preparata blood tonification effect is better than the Radix Rehmanniae, but grows greasy imapirment of the spleen and stomach, and Radix Rehmanniae removing heat from blood is enriched blood, and is difficult for damaging the spleen and stomach, multiselect Radix Rehmanniae during clinical practice; Radix Ginseng Rubra is the cultivation product of Radix Ginseng, and QI invigorating is gentle than Radix Ginseng, so the normal Radix Ginseng Rubra that adopts.So maximum prescriptions is used in inventor Linchuan: 7 parts of Radix Angelicae Sinensis, 3 parts of Radix Hedysari, 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of Periostracum Cicadaes, 3 parts in the Radix Rehmanniae, 1 part of Radix Platycodonis, 2 parts of Rhizoma Chuanxiongs, 5 parts of Radix Rhodiolaes, 5 parts of Radix Ginseng Rubra.
Specify:
Description indication of the present invention " facial paralysis " refers to non-specific facial paralysis, i.e. peripheral facial paralysis.
Claims (8)
1. pharmaceutical composition for the treatment of facial paralysis, it is characterized in that: it is the medicament that is prepared from by following materials of weight proportions medicine:
Radix Angelicae Sinensis 5-7 part, Radix Astragali 5-7 part or Radix Hedysari 3-5 part, Scorpio 1-3 part, Pheretima 2-4 part, Scolopendra 1-3 part, Bombyx Batryticatus 2-4 part, Periostracum Cicadae 2-4 part.
2. the pharmaceutical composition of treatment facial paralysis according to claim 1 is characterized in that: it is the medicament that is prepared from by following materials of weight proportions medicine:
7 parts of Radix Angelicae Sinensis, 5 parts of the Radixs Astragali or 3 parts of Radix Hedysari, 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of Periostracum Cicadaes.
3. pharmaceutical composition for the treatment of facial paralysis, it is characterized in that: it is the medicament that is prepared from by following materials of weight proportions medicine:
Radix Angelicae Sinensis 5-7 part, Radix Astragali 5-7 part or Radix Hedysari 3-5 part, Scorpio 1-3 part, Pheretima 2-4 part, Scolopendra 1-3 part, Bombyx Batryticatus 2-4 part, Periostracum Cicadae 2-4 part, Radix Rehmanniae 3-5 part or Radix Rehmanniae Preparata 1-3 part, Radix Platycodonis 1-2 part, Rhizoma Chuanxiong 2-4 part, Radix Rhodiolae 5-7 part, Radix Ginseng 1-3 part or Radix Ginseng Rubra 5-7 part.
4. the pharmaceutical composition of treatment facial paralysis according to claim 3 is characterized in that: it is the medicament that is prepared from by following materials of weight proportions medicine:
5 parts of 7 parts of Radix Angelicae Sinensis, 5 parts of the Radixs Astragali or 3 parts of Radix Hedysari, 2 parts of Scorpios, 4 parts of Pheretimas, 1 part of Scolopendra, 3 parts of Bombyx Batryticatus, 3 parts of Periostracum Cicadaes, 3 parts in the Radix Rehmanniae or 1 part in Radix Rehmanniae Preparata, 1 part of Radix Platycodonis, 2 parts of Rhizoma Chuanxiongs, 5 parts of Radix Rhodiolaes, 2 parts of Radix Ginsengs or Radix Ginseng Rubra.
5. according to the pharmaceutical composition of each described treatment facial paralysis of claim 1-4, it is characterized in that: the described Radix Astragali adopts Radix Astragali Preparata; Described Radix Hedysari adopts Radix Hedysari Preparata.
6. the preparation of drug combination method of each described treatment facial paralysis of claim 1-4 is characterized in that: adopt the following steps preparation:
A, each crude drug is ground into fine powder, mixes getting final product; Or
B, fine powder is made pill according to a conventional method; Or
Fine powder is pressed into tablet according to a conventional method with fine powder; Or
Make capsule according to a conventional method.
7. the preparation of drug combination method of each described treatment facial paralysis of claim 1-4 is characterized in that: adopt the following steps preparation: each crude drug is mixed adopt the mode of conventional decocting herb to obtain decocting liquid.
8. right is wanted the purposes of each described pharmaceutical composition of 1-4 in the medicine of preparation treatment central facial palsy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010560640XA CN101991638B (en) | 2010-11-26 | 2010-11-26 | Medicine composition for treating facial paralysis as well as preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010560640XA CN101991638B (en) | 2010-11-26 | 2010-11-26 | Medicine composition for treating facial paralysis as well as preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101991638A true CN101991638A (en) | 2011-03-30 |
| CN101991638B CN101991638B (en) | 2012-05-30 |
Family
ID=43782715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010560640XA Expired - Fee Related CN101991638B (en) | 2010-11-26 | 2010-11-26 | Medicine composition for treating facial paralysis as well as preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101991638B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102416036A (en) * | 2011-12-09 | 2012-04-18 | 上海市中医医院 | Chinese medicinal compositions for preventing and treating ventricular reconstruction due to coronary heart disease and use thereof |
| CN104107204A (en) * | 2014-08-08 | 2014-10-22 | 何德亮 | Medicinal composition for treating encephalatrophy and facial paralysis |
| CN105287724A (en) * | 2014-06-15 | 2016-02-03 | 张红伶 | Medicine for treating facioplegia |
| CN106389727A (en) * | 2016-11-11 | 2017-02-15 | 东莞市百替生物科技有限公司 | Traditional Chinese medicine preparation for treating facial paralysis and preparing method thereof |
| CN107550974A (en) * | 2017-10-30 | 2018-01-09 | 潘畅 | Externally-applied medicinal composition of facial paralysis and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101607050A (en) * | 2009-07-22 | 2009-12-23 | 唐浩 | A kind of medicine for the treatment of facial paralysis |
-
2010
- 2010-11-26 CN CN201010560640XA patent/CN101991638B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101607050A (en) * | 2009-07-22 | 2009-12-23 | 唐浩 | A kind of medicine for the treatment of facial paralysis |
Non-Patent Citations (2)
| Title |
|---|
| 《中医药研究》 20001031 李洪志等 自拟双龙五虫汤结合针灸治疗面肌痉挛症 34-35 1-2、5-7 第16卷, 第5期 2 * |
| 《实用医技杂志》 19981231 邓文良等 面瘫诊治临床方药综述 776-777 1-8 第5卷, 第10期 2 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102416036A (en) * | 2011-12-09 | 2012-04-18 | 上海市中医医院 | Chinese medicinal compositions for preventing and treating ventricular reconstruction due to coronary heart disease and use thereof |
| CN102416036B (en) * | 2011-12-09 | 2014-05-07 | 上海市中医医院 | Traditional Chinese medicinal compositions for preventing and treating ventricular reconstruction due to coronary heart disease and use thereof |
| CN105287724A (en) * | 2014-06-15 | 2016-02-03 | 张红伶 | Medicine for treating facioplegia |
| CN104107204A (en) * | 2014-08-08 | 2014-10-22 | 何德亮 | Medicinal composition for treating encephalatrophy and facial paralysis |
| CN106389727A (en) * | 2016-11-11 | 2017-02-15 | 东莞市百替生物科技有限公司 | Traditional Chinese medicine preparation for treating facial paralysis and preparing method thereof |
| CN107550974A (en) * | 2017-10-30 | 2018-01-09 | 潘畅 | Externally-applied medicinal composition of facial paralysis and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101991638B (en) | 2012-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101757569A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis and cerebral infarction and preparation method thereof | |
| CN101991638B (en) | Medicine composition for treating facial paralysis as well as preparation method and application thereof | |
| CN102973685A (en) | Anti-fatigue traditional Chinese medicine preparation and preparation method thereof | |
| CN103830555A (en) | Medicinal liquor as well as preparation method and use thereof | |
| CN1318071C (en) | Chinese medicine preparation for treating bronchitis | |
| CN101711847B (en) | Oral traditional Chinese medicine preparation for treating melancholia and anxiety neurosis | |
| CN104274692A (en) | Jinfo nerve calming liquor and preparation process thereof | |
| CN101269174A (en) | Pharmaceutical composition for improving memory disturbance senile dementia and preparation method thereof | |
| CN103495019B (en) | A kind of tranquilizing by nourishing the heart Chinese medicine preparation and preparation method thereof | |
| CN101856483B (en) | Chinese medicinal composition for treating intermenstrual abnormal emotion and preparation method thereof | |
| CN102008551B (en) | Pharmaceutical composition for treating neck, shoulder and arm pain and preparation method and application thereof | |
| CN103494888A (en) | Traditional Chinese medicine composition capable of replenishing blood and calming nerves and preparation method thereof | |
| CN1686243A (en) | Chinese medicinal formula for treating chronic bronchitis | |
| CN115486488A (en) | Tea drink composition for common food and application thereof | |
| CN101940624B (en) | Chinese medicinal lotion for treating vitiligo | |
| CN101129863A (en) | Traditional Chinese medicine for treating insomnia caused by liver depression transforming into fire | |
| CN1294983C (en) | Medicine for treating facial paralysis and its preparing method | |
| CN101698094B (en) | Distillate for treating white vein diseases and preparation method thereof | |
| CN103638376A (en) | Traditional Chinese medicine tablet for treating rosacea | |
| CN102671115A (en) | Traditional Chinese medicine composition for treating headache and preparation method thereof | |
| CN102697862B (en) | Tuber fleeceflower stem traditional Chinese medicine decoction for relieving insomnia and preparation method for decoction | |
| CN101152389A (en) | Traditional Chinese medicine for treating cestodiasis | |
| CN102228538A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN101152381A (en) | Traditional Chinese medicine for treating hyperemesis gravidarum | |
| CN101940695B (en) | Chinese medicinal ointment for treating vitiligo and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20211126 |